摘要
目的探讨血清和腹腔液CA125在子宫内膜异位症和子宫腺肌症诊断中的价值。方法将2014年8月至2017年8月我院接收的75例子宫内膜异位症和子宫腺肌症患者作为观察组,进而将75例非子宫内膜异位症和子宫腺肌症患者作为对照组,并且通过化学免疫发光法对两组人员的血清和腹腔液CA125水平进行检测。结果观察组经过检测后的腹腔液CA125水平(223.48±43.36)U/mL和血清CA125水平(72.23±14.55)U/mL均高于对照组经过检测后的腹腔液CA125水平(85.78±41.34)U/m L和血清CA125水平(35.65±12.23)U/mL(P<0.05)。结论将血清和腹腔液CA125联合运用于诊断子宫内膜异位症和子宫腺肌症的过程中,对于患者疾病治疗工作的开展拥有良好的效果,值得推广。
Objective to explore the value of serum and peritoneal fluid CA125 in the diagnosis of endometriosis and adenomyosis. Methods 75 cases of endometriosis and adenomyosis received in our hospital from August 2014 to August 2017 were taken as the observation group. Furthermore, 75 patients with non-endometriosis and adenomyosis were taken as the control group, and serum and peritoneal fluid CA125 levels were detected by chemiluminescence. Results The level of peritoneal fluid CA125（223.48±43.36） u/ml and serum CA125 level（72.23±14.55） u/ml after examination in the observation group were higher than that in the control group CA125 levels（85.78±41.34） u/ml and serum CA125 levels（35.65±12.23） u/ml（P 〈0.05）. Conclusion the combination of serum and peritoneal fluid CA125 in the diagnosis of endometriosis and adenomyosis has a good effect on the treatment of patients and is worthy of promotion.
作者
倪娜
NI Na(Jiangning Hospital Affiliated To Naniing Medical University,Nanjing,Jiangsu,211100)
出处
《智慧健康》
2018年第21期19-20,共2页
Smart Healthcare
